A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity

Maurer, Patrik, Jennings, Gary T., Willers, Jörg, Rohner, Franziska, Lindman, Ylva, Roubicek, Kirsten, Renner, Wolfgang A., Müller, Philipp +1 more·2005·European Journal of Immunology
DOI 10.1002/eji.200526285

Cited by (279)

Items 201–279 of 279

  1. Computational method for designing vaccines applied to virus-like particles (VLPs) as epitope carriers
    P. Prosper, Rafael Rodríguez‐Puertas, Diego M. A. Guérin, Maria Marta Branda · 2024 · Vaccine
  2. Nanoparticle-Based Nicotine Vaccine
    Petr O. Ilyinskii, Lloyd P. M. Johnston · 2015 · Springer eBooks
  3. Assessing Neutralized Nicotine Distribution Using Mice Vaccinated with the Mucosal Conjugate Nicotine Vaccine
    Nya L. Fraleigh, Jordan D. Lewicky, Alexandrine L. Martel, Francisco Díaz‐Mitoma, Hoang‐Thanh Le · 2021 · Vaccines
  4. Biopharmaceuticals against substance use disorders – Present and future
    Theofanis Vavilis, Εleni Stamoula, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Georgios Papazisis · 2023 · European Journal of Pharmacology
  5. Virus-Like Particles as Efficient Delivery Platform to Induce a Potent Immune Response
    Fabien Rebeaud, Martin F. Bachmann · 2012 · Springer eBooks
  6. Angiotensin II vaccine: a novel approach in the treatment of hypertension
    Shannon A. Miller, J Roger Accardi, Erin St. Onge · 2008 · Expert Opinion on Biological Therapy
  7. Application of Engineered Viral Nanoparticles in Materials and Medicine
    Michael D. Glidden, John F. Edelbrock, Amy M. Wen, Sourabh Shukla, Yingfang Ma, Roger H. French, Jonathan K. Pokorski, Nicole F. Steinmetz · 2017 · Wiley eBooks
  8. Next-generation immunotherapeutic strategy and clinical advances of vaccines against nicotine addiction
    Kun Yan, Shan Xu, Hufeng Fang, Hao Yang, Dan Su · 2025 · Vaccine
  9. Unconventional Vaccines: Progress and Challenges
    Nikolai Petrovsky · 2013 · Journal of Vaccines & Vaccination
  10. Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders
    Fatima Alamin Awad Alkareem Hamid, Kobra Rostamizadeh, Nicholas Skiados, Nguyet‐Minh Nguyen Le, Debra L. Walter, Bryan Hannon, Courtney Marecki, Yuanzhi Bian, Diego Luengas, Chenming Zhang et al. · 2025 · Journal of Controlled Release
  11. Current Status of Immunologic Approaches to Treating Tobacco Dependence: Vaccines and Nicotine-Specific Antibodies
    Mark G. LeSage, Daniel E. Keyler, Paul R. Pentel · 2008 · Springer eBooks
  12. Anti-nicotine vaccine: current status
    Vishal Prakash Giri, Shubhra Kanodia, Om Giri, K. Sumit · 2015 · International Journal of Basic & Clinical Pharmacology
  13. Vaccines for Opioid Addiction
    Michael D. Raleigh, Paul R. Pentel · 2015 · Springer eBooks
  14. Recent advances in vaccine delivery
    J Soni Khyati, Rakesh Punasiya, Manumari Vaishnavi, Bhupendra Gopalbhai Prajapati, Prajapati Bhupendra G · 2011
  15. Les interventions efficaces pour aider les fumeurs à renoncer au tabac
    Michèle Tremblay, Mohamed Ben Amar · 2008 · Drogues santé et société
  16. Plant-based Vaccines: The Future of Preventive Healthcare?
    Sinan Meriç, Tamer Gümüş, Alp Ayan · 2021 · IntechOpen eBooks
  17. Design Platforms of Nanocapsules for Human Therapeutics or Vaccines
    Masaaki Kawano, Xing Li, Kit S. Lam, Hiroshi Handa, Tatsuo Miyamura, Susan W. Barnett, Indresh K. Srivastava, R. Holland Cheng · 2011
  18. Nasal and Ocular Immunization with Bacteriophage Virus-like Particle Vaccines Elicits Distinct Systemic and Mucosal Antibody Profiles
    Andzoa N. Jamus, Zoe E. R. Wilton, Samantha D. Armijo, Julian Flanagan, Isabella G. Romano, Susan B. Core, Kathryn M. Frietze · 2025 · Vaccines
  19. Hapten Design for Anti-addiction Vaccine Development
    Karen C. Collins, Kim D. Janda · 2015 · Springer eBooks
  20. Noninfectious Disease Vaccines
    Aadil El-Turabi, Martin F. Bachmann · 2017 · Elsevier eBooks
  21. Therapeutic Applications of Nanotechnology in the Prevention of Infectious Diseases
    Rajkumari Mazumdar, Debajit Thakur · 2022 · Nanotechnology in the life sciences
  22. [Recent progress in vaccines against nicotine addiction].
    Guibin Wang, Chuan-jiang Zhu · 2013 · PubMed
  23. Virus‐Like Particles as Antigen Scaffolds
    Bryce Chackerian, John T. Schiller · 2012
  24. Tratamiento farmacológico del tabaquismo
    Sergio Bello S, Alvaro Flores C, MAGDALENA BELLO S · 2008 · Revista chilena de enfermedades respiratorias
  25. Computational mining of MHC class II epitopes for the development of universal immunogenic proteins
    Kyle Saylor, Ben Donnan, Chenming Zhang · 2022 · PLoS ONE
  26. Brain Glucose Metabolism as a Readout of the Central Nervous System Impact of Cigarette Smoke Exposure and Withdrawal and the Effects of NFL-101, as an Immune-Based Drug Candidate for Smoking Cessation Therapy
    Sébastien Goutal, Thi Tran, Claire Leroy, Nadine Benhamouda, Sarah Leterrier, Wadad Saba, Bruno Lafont, Éric Tartour, Marie Roelens, Nicolas Tournier · 2024 · ACS Chemical Neuroscience
  27. NIC6-TT Vaccine Reduces Nicotine-Seeking Behavior and Expression of Nicotine-Induced Locomotor Sensitization in Rats
    Susana Barbosa Méndez, Alberto Salazar‐Juárez · 2025 · Brain Sciences
  28. A divalent nanoparticle vaccine confers robust protective immunity against serotype O FMDV and SVA in pigs
    Nan Cao, YJ Li, Xinghua Chen, Hehai Li, Linxing Tian, Zihui Hu, Yin Bo, Feifei Diao, Huanchun Chen, X Y Li et al. · 2026 · Veterinary Microbiology
  29. Skin Vaccination Against Nicotine Addiction
    Xinyuan Chen, Ji Wang, Jeffrey H. Wu, Mei X. Wu · 2015 · Springer eBooks
  30. El estado actual de las vacunas contra las drogas
    Maura Matus-Ortega, Juan Carlos Calva Nieves, Susana Barbosa-Méndez, Alberto Salazar‐Juárez · 2017 · Revista Internacional de Investigación en Adicciones
  31. Nudge Policy, Embodiment and Intoxication Problems
    Angus Bancroft · 2013
  32. AAV‐Mediated Expression of Methamphetamine Monoclonal Antibody Attenuates Methamphetamine Behaviour Sensitization in Mice
    Yun‐Hsiang Chen, Tsai‐Wei Hung, Yu-Syuan Wang, Eun‐Kyung Bae, Kuo‐Jen Wu, Yun Wang, Seong‐Jin Yu · 2025 · Addiction Biology
  33. Adenovirus-Based Vaccines for the Treatment of Substance Use Disorders
    David F. Havlicek, Jonathan B. Rosenberg, Dolan Sondhi, Ronald G. Crystal, Stephen M. Kaminsky · 2015 · Springer eBooks
  34. Therapeutic Vaccines for Treating Nicotine Addiction
    Matthew W. Kalnik · 2015 · Springer eBooks
  35. Immunotherapy for Obesity
    Tatsuhiko Azegami, Hiroshi Itoh · 2019 · Springer eBooks
  36. Introduction: An overview of the non-parenteral delivery of nanomedicine
    Sara Salatin, Elham Ahmadian, Masumeh Mokhtarpour, Simin Sharifi, Aziz Eftekhari, Maleki Dizaj Solmaz, Shahriar Shahi · 2020 · Elsevier eBooks
  37. Immunotherapeutic Approach to the Treatment and Prevention of Obesity
    Tatsuhiko Azegami, Hiroshi Itoh · 2020 · Springer eBooks
  38. An Innovative Approach in The Field of Health: Nanoparticles/Nanomedicine
    Volkan Enes ERGÜDEN, Alper ÇİFTCİ · 2022 · Journal of Anatolian Environmental and Animal Sciences
  39. Bioengineering and Bioprocessing of Virus-Like Particle Vaccines in Escherichia coli
    Rufika Shari Abidin, Frank Sainsbury · 2022 · Microbiology monographs
  40. Confronting smokers with previously undetected airflow limitation for smoking cessation
    Daniel Kotz · 2008
  41. Smoking cessation treatment and its reimbursement : the costs and effects
    J Kaper · 2006
  42. Nudge Policy, Embodiment and Intoxication Problems
    Angus Bancroft · 2013
  43. Letters to the Editor: Smoking cessation
    Hubertus P. A. Jersmann · 2005 · Australian Prescriber
  44. Letters to the Editor: Ciprofloxacin and fever
    Md Mujibur Rahman · 2005 · Australian Prescriber
  45. Noninfectious disease vaccines
    George R. Siber · 2008 · Elsevier eBooks
  46. Vaccines and Drug-Specific Antibodies
    Mark G. LeSage, Paul R. Pentel · 2010 · Springer eBooks
  47. Design and Development of Recombinant Vaccines with Viral Properties
    Gerd Lipowsky, Martin F. Bachmann · 2011 · Wiley eBooks
  48. Enhancing the efficacy of a nicotine vaccine
    Katherine E. Cornish · 2013 · University of Minnesota Digital Conservancy (University of Minnesota)
  49. Passive Immunization to treat nicotine dependence in rats.
    Samuel A. Roiko · 2009 · University of Minnesota Digital Conservancy (University of Minnesota)
  50. Active immunization against nicotine dependence
    Sabina De Villiers · 2010 · Figshare
  51. Vacunas para la deshabituación tabáquica
    Patricio Garrido, Andrés Prat, Inma Crespo, A. Valverde, Escalante Batista Salvador · 2012 · Vacunas
  52. Recent developments for smoking cessation and treatment of nicotine dependence
    Aracy Pereira Silveira Balbani, Jair Cortez Montovani · 2007 · Expert Opinion on Therapeutic Patents
  53. Novel Pharmacological Treatment Alternatives for Nicotine Dependence
    Nina Lindblom · 2005 · Figshare
  54. Letters to the Editor: Biochemical tests in pregnancy
    Adam Morton · 2005 · Australian Prescriber
  55. Letters to the Editor: 'Statins' and muscle symptoms
    Peter J Stobie · 2005 · Australian Prescriber
  56. Letters to the Editor: Dental dizziness
    Judy Rice · 2005 · Australian Prescriber
  57. Atherosclerotic Risk Factors
    Esther Kim, Heather L. Gornik · 2010 · Elsevier eBooks
  58. Immunological Approaches to Nicotine Addiction
    Tony P. George · 2006 · CRC Press eBooks
  59. Mucosal and systemic antibody responses induced by virus-like particles
    Juliana Bessa · 2008 · Repository for Publications and Research Data (ETH Zurich)
  60. Investigation into Self-Assembling Microcrystals as an alternative to polysaccharide-based conjugate vaccines
    S.-W. Lavelle · 2016 · UCL Discovery (University College London)
  61. Vaccination against nicotine to facilitate smoking cessation
    Tobias Raupach · 2013
  62. Estado actual de las vacunas contra la nicotina: una revisión narrativa
    Susana Barbosa Méndez, Alberto Salazar‐Juárez · 2018 · Vacunas
  63. Current status of nicotine vaccines: A narrative review
    Susana Barbosa Méndez, Alberto Salazar‐Juárez · 2018 · Vacunas (English Edition)
  64. Noninfectious disease vaccines
    Philippe Saudan, Martin F. Bachmann · 2013 · Elsevier eBooks
  65. Delineating Structural Characteristics of Viral Capsid Proteins Critical for Their Functional Assembly.
    Shanshan Cheng · 2014 · Deep Blue (University of Michigan)
  66. Opioid Kullanım Bozukluklarında İmmünoterapi
    Bahadır Geniş, Muhammed Hakan Aksu, Zehra Arıkan · 2021 · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry
  67. An Evaluation of Diverse Therapeutic Interventions for Substance Use Disorders: Serotonergic Hallucinogens, Immunotherapy, and Transcranial Magnetic Stimulation
    William M. Meil, William Farrell, Reem Satti · 2021 · IntechOpen eBooks
  68. Développement de nouveaux adjuvants dérivés de pseudoparticules du virus de la mosaïque de la papaye
    Christian Savard · 2011
  69. Nicotine
    Maher Karam‐Hage, Jennifer A. Minnix, Paul M. Cinciripini · 2010 · Springer eBooks
  70. Behandlung von schädlichem und abhängigem Tabakkonsum
    Stefan Andreas, Anil Batra, Dörthe Brüggmann, Dieter Geyer, H. Gohlke, Thomas Hering, Andreas Jähne, Julia Jückstöck, Marianne Klein, Daniel Kotz et al. · 2022 · Springer eBooks
  71. Immunological Approaches to Nicotine Addiction
    Paul R. Pentel, Mark G. LeSage, Daniel E. Keyler, Dorothy Hatsukami · 2006 · CRC Press eBooks
  72. Noninfectious Disease Vaccines
    Daniel E. Speiser, Aadil El-Turabi, Martin F. Bachmann · 2023 · Elsevier eBooks
  73. Clinical Applications of Nanovaccine Formulation Technology Market Research
    Sunil Kumar, Attuluri Vamsi Kumar, Hardeep Kaur · 2023 · Springer eBooks
  74. Development of a baculovirus-derived chimeric virus-like particles against QX-type avian infectious bronchitis and H9N2 avian influenza
    Bingchen Qiao, Qi Meng, Ni Zhao, Zihe Gao, Yusen Tian, Xiao Hu, Chenfeng Jiang, Xiaofei Song, Jihui Ping · 2025 · Veterinary Vaccine
  75. Safety and Toxicology Profile of TT-6-AmHap Heroin Conjugate Vaccine
    Essie Komla, Erwin G. Abucayon, C. Steven Godin, Agnieszka Sulima, Arthur E. Jacobson, Kenner C. Rice, Gary R. Matyas · 2025 · Vaccines
  76. Pre-clinical characterization of virus-like particles as a platform for nanovaccines against heroin and oxycodone
    Davide Tronconi, Courtney Marecki, Robert W. Seaman, Bryan Hannon, Caroline M. Kim, Fatima Alamin Awad Alkareem Hamid, Marco Pravetoni · 2025 · Vaccine
  77. Futuristic Approaches to Disarming Nicotine Addiction: A Narrative Review of Emerging Therapies
    Chetan Vinay Deshmukh, Vibhuti Dilip Mistry, Prakash Maruti Kasbe, Mayuri Bhikaji Nepale, Snehal Sakharam Patil, Shivani Ahirrao · 2026 · Journal of Indian Association of Public Health Dentistry
  78. Bakteriofago vB_EcoS_NBD2 kilmės nanovamzdelių pritaikymas baltyminių fragmentų eksponavimui
    Aliona Avižinienė · 2022
  79. Plug-and-display labeling system for modular subunit vaccine development
    Weicheng Tang, Lisen Lu, Xiujuan Shi, 杨益民, Deqiang Deng, Mingming Liu, Jonathan F. Lovell, Yao Sun, Honglin Jin · 2026 · Coordination Chemistry Reviews